Past event: Pre-Filled Syringes and Injectable Drug Devices 2024 Conference

Designing Combination Products and Drug Delivery Devices of the Future

The 16th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will return to London in January 2024 to unite leaders from the industry, bringing you the latest advances in the combination product drug delivery space and the chance to collaborate across a 3 day programme.

As part of our leading Injectable Drug Delivery Series, the 3-day event will comprise of a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below addressing the industry’s hottest topics:
  • Device Innovations for Large Volume and Highly Viscous Drug Delivery
  • Sustainability by Design and Material Selection
  • Primary Packaging Development
  • Digital Integration for Connected Devices
This event will not only bring you key insights needed to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in January 2024!

Why attend?

  • The only conference in Europe with 3 full days of dedicated injectable drug delivery presentations
  • 3 full days of networking opportunities
  • 40+ presentations with 70% of speakers from the top 20 big pharma companies
  • The agenda has been curated by an advisory board of big pharma, biotech and drug delivery editorial opinion leaders providing expertise focused on device development, regulatory affairs, human factors and digital health
  • A focus day and 4 dedicated streams addressing the hottest topics in the industry

What you will gain:

  • Opportunity to engage with pharma, biotech and device developers on the latest trends within the pre-filled syringe and injectable device market
  • Hear about new technological advances in the delivery of large volume drugs and novel drug products
  • Understand the latest regulatory requirements from experts surrounding medical devices and digital health
  • Gain insight into how big pharma is incorporating sustainable approaches into drug device design
  • Delve into the growing potential of digital health to improve patient experience and treatment
  • Explore key considerations for material components for the development of primary packaging

Who should attend

Directors, Heads of Departments and Managers for the following areas:
  • Device Development
  • Device Engineering
  • Combination Product Development
  • Drug Delivery Devices
  • Primary Packaging Development
  • Digital Health
  • Sustainability and Circular Economy
  • Large Volume Drug Delivery
  • Novel Drug Product Formulation
  • Regulatory Affairs

Featured Speakers

  • Abha Raveau Violette, Associate Director, Devices and Digital Therapeutics, AstraZeneca
  • Alex Russell, Digital Health Partnerships, Takeda
  • Alexander Prisacar, Scientific Expert for Devices, Boehringer Ingelheim
  • Ali Matour, Principal Device Engineer, GSK
  • Alphons Fakler, Director Human Factors Engineering/User Experience, Novartis
  • Anna Sawicki, Combination Product Design Control Lead, Pfizer R&D UK Limited
  • Annie Zavadil, Device Project Leader, Novartis
  • Bo Kowalczyk, Chief Commercial Officer, ApiJect
  • Cecile Gross, Category Manager Parenteral, Nemera
  • Cedric Gysel, Manager, Sustainable Innovation & Circular Economy Solutions at the Office of Sustainability, Johnson & Johnson
  • Charles Potter, Technical Project Leader, Chiesi Ltd
  • Chris Muenzer, Vice President Innovation and Development, Haselmeier
  • Cinzia Rotella, Project Leader, Sanofi
  • Claus Geiger, Global Medical Device Project Leader, Sanofi
  • Courtney Soulsby, Global Director, Healthcare, BSI Group
  • Cristiana Heese, P&L Development, Boehringer Ingelheim
  • Daanish Ahmed Khan, Director, Novo Nordisk A/S
  • David Harrison, Senior Director, Head of Device Manufacturing Partnerships, UCB Biopharma sprl
  • Elise Legendre, Head of Primary Container & Safety System Development, Sanofi
  • Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
  • Fiona Adshead, Chair, Sustainable Healthcare Coalition
  • George Moore-Arthur, Senior Global Regulatory Professional, Novo Nordisk
  • Hans Jensen, Business Development Leader, Cambridge Design Partnership
  • Haydyn Phillips, Director of User Experience, AstraZeneca
  • Heinrich Martens, Vice President Regulatory Affairs, Fresenius Kabi
  • Jacopo Michieli, Sr. Device Engineer, CSL Behring AG
  • Jennifer Keane, PSL - Procurement Site Lead, Category Buyer Packaging & Devices Manufacturing and Supply, Sanofi
  • Joel Richard, Chief Development Officer, Enterome
  • Julia Frese, Director, TUV SUD Japan Ltd.
  • Julian Dixon, Senior Director, AstraZeneca
  • Khaudeja Bano, Vice President, Combination Product Quality, Amgen
  • Kyle Berman, Principle Engineer, Pfizer Ltd
  • Louisa Harvey, Founder and Principal, Harvey Medical
  • Louise Place, Director, GSK
  • Mark Hassett, Vice President of Business Development, Credence MedSystems
  • Matthew Jones, Senior Medical Sector Manager, DCA Design International
  • Nicola Coles, Sustainability Director, BioPhorum
  • Niels Otterstrom Jensen, Head of TakeBack Program, Novo Nordisk
  • Oli Gould, Sustainable Solutions Lead, Owen Mumford Ltd.
  • Pascal Lagorgette, Head of Product Development, Gerresheimer
  • Richard Crowther, Snr Manager Regulatory Affairs, Amgen
  • Sanjay Kumar Rout, Senior Manager, Device development and Technology Transfer of Medical device Drug device combination product, Biocon Biologics Ltd
  • Sean McPike, Global Product Stewardship Lead, Eli Lilly
  • Steve Hoare, Head of Stds and Regulatory Governance, Secretary, Scientific Director of the BP Commission, Medicines and Healthcare products Regulatory Agency (MHRA)
  • Steven Malbon, Combination & Physical Devices Manager, Medical Engineering Technologies Ltd
  • Theresa Scheuble, Head of Design & Innovation, Johnson & Johnson
  • Thomas Wejs Moeller, Director Global Regulatory Affairs - Device, Novo Nordisk
  • Tina Arien, Associate Director, Janssen Pharmaceutica
  • Ulrich Stahl, Director New Technology, Harro Hofliger

Please fill in your name and email to receive the Conference Agenda of this event.


Leonardo Royal London Tower Bridge
45 Prescot St, E1 8GP
London, United Kingdom

Group rates are available from £179 per night, including VAT & breakfast.
Please click here for the hotel room. To access the group rates, please enter the promo code LHPRUK070124.
Please kindly note this code will only be valid until 4 weeks prior to the event date.
Alternatively you can use which is a helpful site when exploring all your options
Event details
Organizer : SAE Media Group
Event type : Conference
Reference : ASDE-24523